These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 29750289)
1. Pharmacogenomic Primer for the Pediatrician-What Is Really Important? Manzi S Pediatr Ann; 2018 May; 47(5):e217-e219. PubMed ID: 29750289 [TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomic knowledge representation, reasoning and genome-based clinical decision support based on OWL 2 DL ontologies. Samwald M; Miñarro Giménez JA; Boyce RD; Freimuth RR; Adlassnig KP; Dumontier M BMC Med Inform Decis Mak; 2015 Feb; 15():12. PubMed ID: 25880555 [TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics in children. Rieder M Methods Mol Biol; 2014; 1175():687-707. PubMed ID: 25150881 [TBL] [Abstract][Full Text] [Related]
6. [Understanding and reducing the risk of adverse drug reactions in pediatric patients]. Gotta V; van den Anker J; Pfister M Ther Umsch; 2015 Dec; 72(11-12):679-86. PubMed ID: 26654811 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring as a component of personalized medicine: applications in pediatric drug development. Momper JD; Wagner JA Clin Pharmacol Ther; 2014 Feb; 95(2):138-40. PubMed ID: 24253660 [TBL] [Abstract][Full Text] [Related]
12. The challenges of implementing pharmacogenomic testing in the clinic. Moyer AM; Caraballo PJ Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250 [TBL] [Abstract][Full Text] [Related]
13. Application of the structured history taking of medication use tool to optimise prescribing for older patients and reduce adverse events. Cullinan S; O'Mahony D; Byrne S Int J Clin Pharm; 2016 Apr; 38(2):374-9. PubMed ID: 26797770 [TBL] [Abstract][Full Text] [Related]
15. Understanding pharmacogenomic testing and its role in medicine prescribing. Youssef E; Buck J; Wright DJ Nurs Stand; 2020 Jul; 35(7):55-60. PubMed ID: 32524796 [TBL] [Abstract][Full Text] [Related]
17. Regulatory approval for new pharmacogenomic tests: a comparative overview. Joly Y; Koutrikas G; Tassé AM; Issa A; Carleton B; Hayden M; Rieder MJ; Ramos-Paque E; Avard D Food Drug Law J; 2011; 66(1):1-24, i. PubMed ID: 24505844 [TBL] [Abstract][Full Text] [Related]
18. Application of Human Factors Methods to Design Healthcare Work Systems: Instance of the prevention of Adverse Drug Events. Marcilly R; Beuscart-Zephir MC Stud Health Technol Inform; 2015; 215():229-41. PubMed ID: 26249200 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of an electronic medication ordering system (CPOE/CDSS) in hospitalized patients. Vermeulen KM; van Doormaal JE; Zaal RJ; Mol PG; Lenderink AW; Haaijer-Ruskamp FM; Kosterink JG; van den Bemt PM Int J Med Inform; 2014 Aug; 83(8):572-80. PubMed ID: 24929633 [TBL] [Abstract][Full Text] [Related]
20. Preventability of Voluntarily Reported or Trigger Tool-Identified Medication Errors in a Pediatric Institution by Information Technology: A Retrospective Cohort Study. Stultz JS; Nahata MC Drug Saf; 2015 Jul; 38(7):661-70. PubMed ID: 26013909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]